Placebo News and Research

RSS

Antioxidants do not improve sperm quality in infertile men, finds study

A large clinical trial has shown that daily antioxidant supplementation among men with infertility does not make a difference to the quality of their sperm.

2 Jul 2018

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today announced that U.S. researchers published scientific findings recommending development of anti-Liver Cancer Drugs based on a mechanism of action utilized by Namodenoson.

2 Jul 2018

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

2 Jul 2018

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

Researchers from the University of Granada have developed new medication which could help to treat and prevent chemotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients.

30 Jun 2018

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Atlantic Health System is now enrolling patients in four pancreatic cancer clinical trials. Angela Alistar, MD, a nationally known expert on pancreatic cancer, is serving as national Principal Investigator on the first trial and as local PI on three other trials.

30 Jun 2018

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

29 Jun 2018

URI researchers working to develop novel medication to treat alcohol use disorder

Alcohol abuse is among the leading causes of preventable death in the United States, killing more than 88,000 people a year, according to the Centers for Disease Control.

28 Jun 2018

Consuming dark chocolate has no significant effect on woman's muscle recovery

The various health benefits from consuming dark chocolate are highly researched with claims that the antioxidants it contains can help people recover from a tough workout. But research from a University of Huddersfield student, studying Sports and Exercise Nutrition, has concluded it has no significant effect on a woman's muscle recovery post-exercise, posing a need for further research.

28 Jun 2018

Worldwide study to examine new treatments for IgA nephropathy

A patient from Birmingham is the first person to be recruited into a new worldwide study to test new treatments for a potentially life-threatening kidney condition called IgA nephropathy.

28 Jun 2018

FDA approves cannabis based drug for severe form of epilepsy

The U.S. Food and Drug Administration (FDA) on the 25th of June 2018 approved Epidiolex oral solution that is essentially cannabidiol or the active component of marijuana or cannabis. As of now the drug is approved for use in two rare forms of epilepsy - Lennox-Gastaut syndrome and Dravet syndrome. The approval comes for individuals over two years of age.

28 Jun 2018

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

Administering nitric oxide gas after heart surgery may decrease risk of kidney problems

Administration of nitric oxide gas during and for 24 hours following heart surgery decreased the risk of patients developing acute and chronic kidney problems, a randomized, controlled trial conducted in China found.

22 Jun 2018

Probiotics could cut age-related bone loss in elderly women

For the first time in the world, researchers at the University of Gothenburg, Sweden, have demonstrated that probiotics, dietary supplements with health-promoting bacteria, can be used to affect the human skeleton.

21 Jun 2018

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, today provided an update on its Phase II clinical trial with drug candidate Namodenoson in the treatment of advanced hepatocellular carcinoma in patients whose disease has progressed on sorafenib therapy.

19 Jun 2018

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its program to develop a defined bacterial product for ulcerative colitis (UC). Financial details have not been disclosed.

19 Jun 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Placebo News and Research

Antioxidants do not improve sperm quality in infertile men, finds study

U.S. researchers recommend development of anti-cancer drugs based on mechanism of Namodenoson

Psychedelics and their role in treatment of mental health disorders

New medication may treat chemotherapy, radiotherapy-induced oral mucositis

Atlantic Health System starts enrolling patients in four pancreatic cancer clinical trials

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

URI researchers working to develop novel medication to treat alcohol use disorder

Consuming dark chocolate has no significant effect on woman's muscle recovery

Worldwide study to examine new treatments for IgA nephropathy

FDA approves cannabis based drug for severe form of epilepsy

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

Administering nitric oxide gas after heart surgery may decrease risk of kidney problems

Probiotics could cut age-related bone loss in elderly women

Can-Fite provides update on Phase II clinical trial with drug candidate Namodenoson

Microbiotica partners with University of Adelaide to develop defined bacterial product for ulcerative colitis

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

NIAID launches clinical trial of investigational RSV vaccine

Topical gel may lower breast cancer risk in women with dense breast tissue

New clinical trial of MS drug will be first to recognize needs of wheelchair users

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News